HK1063798A1 - Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers - Google Patents
Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamersInfo
- Publication number
- HK1063798A1 HK1063798A1 HK04106661.1A HK04106661A HK1063798A1 HK 1063798 A1 HK1063798 A1 HK 1063798A1 HK 04106661 A HK04106661 A HK 04106661A HK 1063798 A1 HK1063798 A1 HK 1063798A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rotamers
- compositions
- preparation
- pharmaceutically active
- increased amount
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33433101P | 2001-11-29 | 2001-11-29 | |
US37391602P | 2002-04-19 | 2002-04-19 | |
PCT/US2002/038112 WO2003048153A1 (fr) | 2001-11-29 | 2002-11-26 | Procede de preparation de compositions presentant une quantite augmentee de sels pharmaceutiquement actifs de rotameres |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1063798A1 true HK1063798A1 (en) | 2005-01-14 |
Family
ID=26989151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04106661.1A HK1063798A1 (en) | 2001-11-29 | 2004-09-03 | Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
Country Status (12)
Country | Link |
---|---|
US (2) | US6943251B2 (fr) |
EP (1) | EP1451174B1 (fr) |
JP (2) | JP2005511693A (fr) |
CN (1) | CN1596254A (fr) |
AR (1) | AR037679A1 (fr) |
AT (1) | ATE478065T1 (fr) |
AU (1) | AU2002346569A1 (fr) |
CA (1) | CA2468525A1 (fr) |
DE (1) | DE60237388D1 (fr) |
HK (1) | HK1063798A1 (fr) |
MX (1) | MXPA04005210A (fr) |
WO (1) | WO2003048153A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689765B2 (en) * | 1999-05-04 | 2004-02-10 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
CN1596254A (zh) * | 2001-11-29 | 2005-03-16 | 先灵公司 | 含有增加量的旋转异构体的药物活性盐的组合物的制备方法 |
JP4538237B2 (ja) * | 2002-03-29 | 2010-09-08 | シェーリング コーポレイション | Ccr5アンタゴニストとしてのピペリジン化合物およびピペラジン化合物の合成 |
US7244765B2 (en) * | 2004-06-25 | 2007-07-17 | Cytokine Pharmasciences, Inc | Guanylhydrazone salts, compositions, processes of making and methods of using |
CN101133048A (zh) | 2005-01-06 | 2008-02-27 | 先灵公司 | 哌嗪化合物的药用盐制备 |
WO2007038496A2 (fr) * | 2005-09-27 | 2007-04-05 | Chemic Laboratories, Inc. | Synthese d'esters d'alcools gras d'acides a-hydroxy-carboxyliques, leurs utilisation comme renforçateurs de permeation percutanee, et gels topiques pour l'administration transdermique de steroides |
US7561458B2 (en) * | 2006-12-26 | 2009-07-14 | Texas Instruments Incorporated | Ferroelectric memory array for implementing a zero cancellation scheme to reduce plateline voltage in ferroelectric memory |
BR112012022873B1 (pt) | 2010-03-11 | 2021-09-14 | Wyeth Llc | Composição farmacêutica para administração oral compreendendo brometo de metilnaltrexona e dodecil sulfato de sódio |
US20170197980A1 (en) * | 2014-06-25 | 2017-07-13 | Abbvie Inc. | N-(4-phenyl)-n'-(3-fluorophenyl)urea docusate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391865B1 (en) * | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
ATE299865T1 (de) * | 1999-05-04 | 2005-08-15 | Schering Corp | Piperazinderivate verwendbar als ccr5 antagonisten |
JP3874229B2 (ja) * | 1999-07-02 | 2007-01-31 | Tdk株式会社 | 圧電セラミックスおよびこれを用いた圧電デバイス |
CN1596254A (zh) * | 2001-11-29 | 2005-03-16 | 先灵公司 | 含有增加量的旋转异构体的药物活性盐的组合物的制备方法 |
-
2002
- 2002-11-26 CN CNA028238079A patent/CN1596254A/zh active Pending
- 2002-11-26 AU AU2002346569A patent/AU2002346569A1/en not_active Abandoned
- 2002-11-26 AT AT02784638T patent/ATE478065T1/de not_active IP Right Cessation
- 2002-11-26 JP JP2003549343A patent/JP2005511693A/ja active Pending
- 2002-11-26 EP EP02784638A patent/EP1451174B1/fr not_active Expired - Lifetime
- 2002-11-26 US US10/304,674 patent/US6943251B2/en not_active Expired - Fee Related
- 2002-11-26 WO PCT/US2002/038112 patent/WO2003048153A1/fr active Application Filing
- 2002-11-26 DE DE60237388T patent/DE60237388D1/de not_active Expired - Lifetime
- 2002-11-26 CA CA002468525A patent/CA2468525A1/fr not_active Abandoned
- 2002-11-26 MX MXPA04005210A patent/MXPA04005210A/es active IP Right Grant
- 2002-11-27 AR ARP020104560A patent/AR037679A1/es unknown
-
2004
- 2004-09-03 HK HK04106661.1A patent/HK1063798A1/xx not_active IP Right Cessation
-
2005
- 2005-03-30 US US11/093,560 patent/US7534884B2/en not_active Expired - Fee Related
-
2010
- 2010-03-03 JP JP2010047148A patent/JP2010132705A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2002346569A1 (en) | 2003-06-17 |
JP2005511693A (ja) | 2005-04-28 |
CN1596254A (zh) | 2005-03-16 |
EP1451174A2 (fr) | 2004-09-01 |
US7534884B2 (en) | 2009-05-19 |
AR037679A1 (es) | 2004-12-01 |
US20030144510A1 (en) | 2003-07-31 |
EP1451174B1 (fr) | 2010-08-18 |
US6943251B2 (en) | 2005-09-13 |
WO2003048153A8 (fr) | 2004-06-03 |
MXPA04005210A (es) | 2004-08-19 |
AU2002346569A8 (en) | 2003-06-17 |
WO2003048153A1 (fr) | 2003-06-12 |
US20050171117A1 (en) | 2005-08-04 |
ATE478065T1 (de) | 2010-09-15 |
CA2468525A1 (fr) | 2003-06-12 |
DE60237388D1 (de) | 2010-09-30 |
JP2010132705A (ja) | 2010-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI315204B (en) | Oral dosage forms for propiverine or pharmaceutically acceptable salts thereof having prolonged release of the active agent | |
HUP0401763A3 (en) | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them and process for preparation the compounds | |
HUP0401642A3 (en) | Use of staurosporine derivatives for the preparation of pharmaceutical compositions | |
HUP0004120A3 (en) | Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy | |
HUP0401083A3 (en) | 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds | |
HUP0200402A3 (en) | An improved process for the preparation of non-hygroscopic salts of l(-)-carnitine | |
AU2002341241A1 (en) | Process for the preparation of fast dissolving dosage form | |
HUP0303487A3 (en) | Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anthiarhythmic agents and process for preparation of the compounds | |
HK1063798A1 (en) | Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers | |
EP1407780A4 (fr) | Compositions hemostatiques pharmaceutiquement stables | |
HUP0302594A3 (en) | Process for the preparation of phenethylamine derivatives | |
HUP0102159A3 (en) | Pharmaceutical composition for the treatment of rumen acidosis | |
GB0107751D0 (en) | Pharmaceutically active compounds | |
HUP0303178A3 (en) | Methods and compositions for reducing the taste of pharmaceutically active agents | |
IL153532A0 (en) | Process for the preparation of pyrazolopyrimidinones | |
GB0106631D0 (en) | Pharmaceutically active compounds | |
EP1176150A4 (fr) | Procede de preparation de derives de trifluorothymidine | |
HUP0200311A3 (en) | Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions | |
IL135993A0 (en) | Pharmaceutical composition for the treatment of fibrosis | |
AU2002348105A1 (en) | Oral dosage forms for improving the bioavailability of therapeutic agents | |
SI1283845T1 (en) | Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine | |
IL136687A0 (en) | Pharmaceutical composition for the treatment of multiple sclerosis | |
HUP0103049A3 (en) | Use of fluexetine for preparation of pharmaceutical compositions | |
HU0003973D0 (en) | Pharmaceutical composition for the treatment of aids | |
AU2002313877A1 (en) | The process for the preparation of the acesulfam salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20131126 |